#Pcsk9

A single gene-editing infusion from Verve Therapeutics permanently disabled the PCSK9 gene in the liver, reducing LDL cholesterol by an average of 62% in patients with inherited high cholesterol, with effects lasting at least six months.…

15s

Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial

🖼️

0Read More

Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial

Ars Technica - All content·Beth Mole·5 months ago

#R8n5kdGO

#arstechnica #pcsk9 #verve #dose #gene

The interim Phase I trial data was only from 35 people, but results look good so far.

15s

New treatment cuts bad cholesterol by nearly 50% without statins

📰

0Read More

New treatment cuts bad cholesterol by nearly 50% without statins

ScienceDaily·6 months ago

#pHDFrZvL

#heartdisease #liverdisease #cholesterol #strokeprevention #diseasesandconditions

A new breakthrough could change how high cholesterol is treated, offering a powerful alternative to traditional drugs. Researchers have developed tiny DNA-based molecules that shut down PCSK9—a key protein that keeps “bad” LDL cholesterol circulating in…

15s

Menu

#Pcsk9

The Genius New Way to Lower Cholesterol Has Nothing to Do With Diet or Exercise

One-Time Gene Editing Infusion Lowers LDL Cholesterol by 62% for 6+ Months

Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial

New treatment cuts bad cholesterol by nearly 50% without statins